We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
+9.96%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$2.79B
AUM Growth
-$56M
Cap. Flow
-$584M
Cap. Flow %
-20.93%
Top 10 Hldgs %
31.86%
Holding
129
New
19
Increased
19
Reduced
27
Closed
26

Top Buys

Rank Stock Value
1
AERI
Aerie Pharmaceuticals
AERI
+$67.9M
2
XENT
Intersect ENT, Inc
XENT
+$33.9M
3
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$32.9M
4
NVRO
NEVRO CORP.
NVRO
+$32.8M
5
ACHC icon
Acadia Healthcare
ACHC
+$27.2M

Top Sells

Rank Stock Value
1
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
+$130M
2
TNDM icon
Tandem Diabetes Care
TNDM
+$80M
3
AET
Aetna Inc
AET
+$42M
4
CVS icon
CVS Health
CVS
+$39.3M
5
WBA
Walgreens Boots Alliance
WBA
+$31.9M

Sector Composition

Rank Sector Weight
1 Healthcare 68.65%
2 Financials 1.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRTA icon
101
Prothena Corp
PRTA
$451M
– –
-628,262
Closed -$9.16M
SLDB icon
102
Solid Biosciences
SLDB
$842M
– –
-11,959
Closed -$6.39M
STIM icon
103
Neuronetics
STIM
$141M
– –
-125,000
Closed -$3.33M
WBA
104
DELISTED
Walgreens Boots Alliance
WBA
– –
-531,000
Closed -$31.9M
WVE icon
105
Wave Life Sciences
WVE
$1.11B
– –
-178,806
Closed -$6.84M
XNCR icon
106
Xencor
XNCR
$1.4B
– –
-48,366
Closed -$1.79M
TECX
107
Tectonic Therapeutic
TECX
$615M
– –
-16,667
Closed -$5.71M
LCI
108
DELISTED
Lannett Company, Inc.
LCI
– –
-450,338
Closed -$24.5M
SRRA
109
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
– –
-44,122
Closed -$5.22M
ARNA
110
DELISTED
Arena Pharmaceuticals Inc
ARNA
– –
-398,194
Closed -$17.4M
TBIO
111
DELISTED
Translate Bio, Inc. Common Stock
TBIO
– –
-650,000
Closed -$8.22M
NEOS
112
DELISTED
Neos Therapeutics, Inc
NEOS
– –
-233,332
Closed -$1.46M
WMGI
113
DELISTED
Wright Medical Group Inc
WMGI
– –
-349,539
Closed -$9.07M
MNK
114
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
– –
-6,988,248
Closed -$130M
FTSV
115
DELISTED
Forty Seven, Inc. Common Stock
FTSV
– –
-600,000
Closed -$9.6M
AET
116
DELISTED
Aetna Inc
AET
– –
-229,000
Closed -$42M
IVTY
117
DELISTED
Invuity, Inc
IVTY
– –
-2,336,889
Closed -$9.11M
STDY
118
DELISTED
SteadyMed Ltd
STDY
– –
-918,120
Closed -$4.13M
ARLZ
119
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
– –
-1,644,583
Closed -$576K
1 2 3 4
5

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q3 2018 Portfolio in Review

As of Q3 2018, Deerfield Management held 129 positions worth $2.79B, down 2% from $2.85B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Deerfield Management withdrew a net $584M in Q3 2018, closing 26 positions and reducing 27 holdings. Its most notable exit was MALLINCKRODT PUBLIC LIMITED COMPANY, an estimated $130M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 69% of assets, down from 74% a quarter earlier, followed by Financials.

Against the trend, Deerfield Management opened a new position in NEVRO CORP. worth $29.9M.

  • Deerfield Management's largest Q3 2018 buy was NEVRO CORP.: 525,040 shares worth $29.9M.
  • Deerfield Management added most to Aerie Pharmaceuticals in Q3 2018, an estimated $67.9M increase.
  • Deerfield Management's biggest Q3 2018 reduction was Tandem Diabetes Care, cutting an estimated $80M.
  • Deerfield Management fully exited MALLINCKRODT PUBLIC LIMITED COMPANY in Q3 2018, selling an estimated $130M.
  • Deerfield Management's ten largest holdings make up 32% of its $2.79B portfolio in Q3 2018.
  • Deerfield Management opened 19 new positions and closed 26 in Q3 2018.
  • Deerfield Management's portfolio value fell 2% quarter-over-quarter to $2.79B.

Based on Deerfield Management's 13F filing for Q3 2018, filed 14 Nov 2018.